Back to newsAmneal Pharmaceuticals target price raised to $28 from $25AAMRX•2026-11-06UBS raised its target price for Amneal Pharmaceuticals to $28 from $25.Related NewsMMcGraw Hill, Inc.: UBS cuts target price to $14 from $15MH•2026-11-06CUBS raises CarGurus target price to $36 from $35CARG•2026-11-06RRoyal Gold: UBS raises target price to $300 from $285RGLD•2026-11-06SStarbucks Corp: UBS raises target price to $110 from $105SBUX•2026-11-06OOwens Corning: UBS cuts target price to $170 from $198OC•2026-11-06